Search results for "slas europe 2018"
25
Selected Filters:
Industry News
FDA approves the first CAR T treatment for relapsed or refractory mantle cell lymphoma
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
SelectScience Interviews
Dr. Frank Peacock on the Importance of Communicating New Practices in Medicine
Application Note
Monitoring compliance with heavy metals limits in baby food
RosetteSep™ HLA Myeloid Cell Enrichment Kit
STEMCELL Technologies Inc.Immunodensity negative selection cocktail
RosetteSep™ HLA T Cell Enrichment Cocktail
STEMCELL Technologies Inc.Immunodensity negative selection cocktail
RosetteSep™ HLA B Cell Enrichment Cocktail
STEMCELL Technologies Inc.Immunodensity negative selection cocktail
Industry News
New tech spin-outs could boost fruit and veg yields
Industry News
Avacta and LG Chem Life Sciences expand partnership
Application Note
Safety Solutions and Innovations for Your Lab
Editorial Article
Applying Biosensor Innovations to Healthcare and Medicine
GC/MS/MS Dioxins in Food and Feed Analyzer
Agilent TechnologiesBuilt around the 7010 Series Triple Quadrupole GC/MS, the Dioxins Food and Feed Analyzer provides the sensitivity required for trace dioxin and dioxin-like PCB detection.
Editorial Article
SelectScience and ELRIG partner to pioneer digital event experience
On July 3, SelectScience and ELRIG will be hosting an online event showcasing advances in cell-based screening in drug discovery to extend high-quality content to the global audience
Expert Insights
Ask New Research Questions with the Latest Live Cell Imaging Technology
Learn how scientists around the world are using IncuCyte technology to investigate dynamic biological processes in real time
Industry News
New Temperature Control Solutions at ACHEMA
Huber Kältemaschinenbau shows Temperature Control Solutions for Laboratory and Process Industry
Product News
Abbott Launches First-Ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
The Afinion HbA1c Dx test provides results in just three minutes, enabling clinicians to develop informed and individualized patient care plans
Industry News
Recent Crizotinib Trial Indicates a Promising Outcome for ALK-Positive Sufferers
Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate
